High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.3M
$4,298,076
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $131,609x2 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $2,762,822Largex11 | S | Form 4 |
|
LGND
M
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
Other
2026-03-04
$261,350
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
Other
|
2026-03-04 | $261,350 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$1,031,770Largex11
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $1,031,770Largex11 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $141,383 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2026-03-03 | $409,851 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $93,632x6 | S | Form 4 |